PL3272343T3 - Tapentadol w prewencji i leczeniu depresji i lęku - Google Patents

Tapentadol w prewencji i leczeniu depresji i lęku

Info

Publication number
PL3272343T3
PL3272343T3 PL17185830T PL17185830T PL3272343T3 PL 3272343 T3 PL3272343 T3 PL 3272343T3 PL 17185830 T PL17185830 T PL 17185830T PL 17185830 T PL17185830 T PL 17185830T PL 3272343 T3 PL3272343 T3 PL 3272343T3
Authority
PL
Poland
Prior art keywords
tapentadol
anxiety
preventing
treating depression
depression
Prior art date
Application number
PL17185830T
Other languages
English (en)
Inventor
Ilona STEIGERWALD
Ulrich Jahnel
Thomas Tzschentke
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of PL3272343T3 publication Critical patent/PL3272343T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL17185830T 2011-04-29 2012-04-27 Tapentadol w prewencji i leczeniu depresji i lęku PL3272343T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11003508 2011-04-29
PCT/EP2012/001819 WO2012146383A1 (en) 2011-04-29 2012-04-27 Tapentadol for preventing and treating depression and anxiety
EP17185830.1A EP3272343B1 (en) 2011-04-29 2012-04-27 Tapentadol for preventing and treating depression and anxiety
EP12720794.2A EP2701693B1 (en) 2011-04-29 2012-04-27 Tapentadol for preventing and treating depression and anxiety

Publications (1)

Publication Number Publication Date
PL3272343T3 true PL3272343T3 (pl) 2020-07-27

Family

ID=44260882

Family Applications (2)

Application Number Title Priority Date Filing Date
PL12720794T PL2701693T3 (pl) 2011-04-29 2012-04-27 Tapentadol do profilaktyki i leczenia depresji i lęku
PL17185830T PL3272343T3 (pl) 2011-04-29 2012-04-27 Tapentadol w prewencji i leczeniu depresji i lęku

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL12720794T PL2701693T3 (pl) 2011-04-29 2012-04-27 Tapentadol do profilaktyki i leczenia depresji i lęku

Country Status (15)

Country Link
US (3) US20120277319A1 (pl)
EP (3) EP3656380A1 (pl)
JP (3) JP6014655B2 (pl)
CY (2) CY1119586T1 (pl)
DK (2) DK2701693T3 (pl)
ES (2) ES2788548T3 (pl)
HR (2) HRP20171570T1 (pl)
HU (2) HUE034003T2 (pl)
LT (2) LT3272343T (pl)
NO (1) NO2701693T3 (pl)
PL (2) PL2701693T3 (pl)
PT (2) PT3272343T (pl)
RS (2) RS60152B1 (pl)
SI (2) SI2701693T1 (pl)
WO (1) WO2012146383A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
RU2015138422A (ru) 2009-07-22 2018-12-25 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
PE20141638A1 (es) 2011-07-29 2014-11-22 Gruenenthal Chemie Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
RS56527B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
CN107660147B (zh) * 2015-05-26 2021-04-30 抗菌技术生物技术研究与发展股份有限公司 用于治疗帕金森病和相关障碍的组合物
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
US10292948B2 (en) * 2017-01-11 2019-05-21 Torrent Pharmaceuticals Limited Tapentadol nasal composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
WO2007025286A2 (en) 2005-08-26 2007-03-01 The Board Of Trustees Of The Leland Stanford Junior University Therapy procedure for drug delivery for trigeminal pain
US20090306050A1 (en) 2006-02-03 2009-12-10 Timothy Dinan Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
HRP20110271T1 (hr) 2006-04-28 2011-05-31 Grnenthal Gmbh Farmaceutska kombinacija koja sadrži 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i nsaid (nesteroidni antiinflamatorni lijek)
DE102007012165A1 (de) 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
EP2219633A2 (en) 2007-11-23 2010-08-25 Nectid, Inc. Tapentadol compositions
JP2011507800A (ja) 2007-12-26 2011-03-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 癲癇、精神障害、または感覚器官の障害のためのａｍｐａ受容体アンタゴニスト
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
US7872046B2 (en) 2008-01-25 2011-01-18 Xenoport, Inc. Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
US20100227921A1 (en) 2009-03-03 2010-09-09 Shire Llc Amino acid and peptide carbamate prodrugs of tapentadol and uses thereof
JP5993303B2 (ja) 2009-04-30 2016-09-14 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング リウマチ性痛を治療するための１−フェニル−３−ジメチルアミノプロパン化合物の使用
FR2970261B1 (fr) 2011-01-10 2013-05-03 IFP Energies Nouvelles Procede d'hydrotraitement de charges lourdes d'hydrocarbures avec des reacteurs permutables incluant au moins une etape de permutation progressive
EP2694049B1 (en) 2011-04-05 2018-10-31 Grünenthal GmbH Tapentadol for preventing chronification of pain

Also Published As

Publication number Publication date
EP2701693B1 (en) 2017-08-23
ES2788548T3 (es) 2020-10-21
US9980927B2 (en) 2018-05-29
EP3656380A1 (en) 2020-05-27
ES2646363T3 (es) 2017-12-13
SI3272343T1 (sl) 2020-06-30
HRP20200600T1 (hr) 2020-10-16
EP3272343A1 (en) 2018-01-24
PT3272343T (pt) 2020-04-23
RS60152B1 (sr) 2020-05-29
NO2701693T3 (pl) 2018-01-20
PT2701693T (pt) 2017-11-16
CY1119586T1 (el) 2018-03-07
LT2701693T (lt) 2017-11-10
JP6014655B2 (ja) 2016-10-25
LT3272343T (lt) 2020-05-11
PL2701693T3 (pl) 2018-01-31
JP6445637B2 (ja) 2018-12-26
US20150018426A1 (en) 2015-01-15
DK3272343T3 (da) 2020-04-27
HUE034003T2 (en) 2018-02-28
EP2701693A1 (en) 2014-03-05
CY1123051T1 (el) 2021-10-29
SI2701693T1 (sl) 2017-11-30
DK2701693T3 (da) 2017-11-13
RS56523B1 (sr) 2018-02-28
WO2012146383A1 (en) 2012-11-01
HUE049308T2 (hu) 2020-09-28
EP3272343B1 (en) 2020-02-12
JP2017031182A (ja) 2017-02-09
JP2018021053A (ja) 2018-02-08
US20170196822A1 (en) 2017-07-13
US20120277319A1 (en) 2012-11-01
JP2014516935A (ja) 2014-07-17
HRP20171570T1 (hr) 2017-11-17

Similar Documents

Publication Publication Date Title
LT3272343T (lt) Tapentadolis, skirtas depresijos ir nerimo prevencijai ir gydymui
ZA201401526B (en) Method and formulation for inhalation
EP2768443A4 (en) METHODS AND DEVICES FOR TREATING HYPERTENSION
EP2615533A4 (en) INTERACTION PROCEDURE AND INTERACTION DEVICE
PL2696754T3 (pl) Urządzenie i sposób pomiaru stresu
IL229844B (en) Anti-psgl-1 antibodies and their use
PT2663864T (pt) Método de avaliação de imunodiversidade e seu uso
GB201122195D0 (en) Composition and method
GB201408236D0 (en) Composition and method
GB201110783D0 (en) Methods and uses
EP2757849A4 (en) METHOD AND DEVICE FOR MULTI-CARRIER PLANNING
EP2755363A4 (en) METHOD AND DEVICE FOR FAST DATA DISTRIBUTION
GB201116774D0 (en) Uses and methods
GB201101862D0 (en) Method and device
SI2683245T1 (sl) Postopki in sestavki za zdravljenje depresije z uporabo ciklobenzaprina
PT2697875T (pt) Dispositivo antiestático e método operativo associado
PL2667710T3 (pl) Kompozycja owadobójcza i związane z nią sposoby
GB201106433D0 (en) Composition and method
IL215720A (en) Air dryer and its method of use
EP2721788A4 (en) METHOD AND ARRANGEMENT FOR SENDING QUESTIONS
GB2489303B (en) Preserved-traveltime smoothing method and device
PL2663585T3 (pl) Związki oligomocznika oraz sposób ich wytwarzania i ich zastosowanie
GB201108490D0 (en) Methods and uses
PT2508592T (pt) Resumo
GB201109991D0 (en) Process and device